Status: current, Defined. Date: 31-Jul 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3429301000168111 | Bydureon (exenatide 2 mg) modified release injection, 2 mg chamber (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3429311000168114 | Bydureon (exenatide 2 mg) modified release injection, 2 mg chamber | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Bydureon (exenatide 2 mg) modified release injection, 2 mg chamber | Is a | exenatide 2 mg modified release injection, chamber | true | Inferred relationship | Some | ||
| Bydureon (exenatide 2 mg) modified release injection, 2 mg chamber | Is a | Bydureon | true | Inferred relationship | Some | ||
| Bydureon (exenatide 2 mg) modified release injection, 2 mg chamber | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Bydureon (exenatide 2 mg) modified release injection, 2 mg chamber | has manufactured dose form | modified release injection | true | Inferred relationship | Some | ||
| Bydureon (exenatide 2 mg) modified release injection, 2 mg chamber | has unit of use | chamber | true | Inferred relationship | Some | 322086561 | |
| Bydureon (exenatide 2 mg) modified release injection, 2 mg chamber | has intended active ingredient | exenatide | true | Inferred relationship | Some | 322086560 | |
| Bydureon (exenatide 2 mg) modified release injection, 2 mg chamber | has Australian BoSS | exenatide | true | Inferred relationship | Some | 322086560 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Bydureon (1 x 2 mg chamber, 1 x inert diluent chamber), 1 dual chamber pen device | has TPUU | True | Bydureon (exenatide 2 mg) modified release injection, 2 mg chamber | Inferred relationship | Some | 2 |
| Bydureon (1 x 2 mg chamber, 1 x inert diluent chamber), 1 dual chamber pen device | has TPUU | True | Bydureon (exenatide 2 mg) modified release injection, 2 mg chamber | Inferred relationship | Some | 1 |
| Bydureon (1 x 2 mg chamber, 1 x inert diluent chamber), 4 dual chamber pen devices | has TPUU | True | Bydureon (exenatide 2 mg) modified release injection, 2 mg chamber | Inferred relationship | Some | 2 |
| Bydureon (1 x 2 mg chamber, 1 x inert diluent chamber), 4 dual chamber pen devices | has TPUU | True | Bydureon (exenatide 2 mg) modified release injection, 2 mg chamber | Inferred relationship | Some | 2 |
Reference Sets
Trade product unit of use reference set
FHIR